CELEX ONCOLOGY INNOVATIONS LIMITED

101 NEW CAVENDISH STREET, 1ST FLOOR SOUTH, LONDON  W1W 6XH
  • Active
  • Private Limited Company
  • Company No. 11085607
  • Last Updated: 01 Mar 2024

Company Profile

CELEX ONCOLOGY INNOVATIONS LIMITED was incorporated on Tuesday, November 28, 2017 as a Private Limited Company with registered address in LONDON. CELEX ONCOLOGY INNOVATIONS LIMITED has the status: Active and it's listed in the following category: Manufacture of basic pharmaceutical products. This Private Limited Company has been operating for 6 years 11 months and 11 days.

Name CELEX ONCOLOGY INNOVATIONS LIMITED
Company number 11085607
Company type Private Limited Company
Incorporation date 28 Nov 2017
Status Active
Industry (SIC 2007)

Address

Registered Address 101 NEW CAVENDISH STREET
1ST FLOOR SOUTH
LONDON
W1W 6XH
Country Of Origin UNITED KINGDOM

Map based on PostCode

Ownership Information

Individuals and organizations with significant control over the business either by owning at least 25% shares or by virtue of significant influence over the business.

Name Nature of Control
Dr Vasileios Xeniades Nationality: Greek Dates: Wednesday, September 25, 2019 - Monday, June 8, 2020
significant influence or control
Professor Mustafa Bilgin Ali Djamgoz Nationality: British Dates: Tuesday, November 28, 2017 - present
ownership of shares 50 to 75 percent
voting rights 50 to 75 percent
right to appoint and remove directors
Mr Laurence John Cohen Nationality: United Kingdom Dates: Tuesday, November 28, 2017 - Wednesday, September 25, 2019
ownership of shares 25 to 50 percent
voting rights 25 to 50 percent

Accounts and Confirmation

Type of accounts TOTAL EXEMPTION FULL
End of financial Year 31 December
Next annual accounts due 30 September 2024, (-40 days left)
Latest accounts 31 December 2022
Next confirmation statement due 26 December 2018
Last confirmation statement dated Not available

Mortgages

No mortgages have been registered against CELEX ONCOLOGY INNOVATIONS LIMITED.

Previous Names

Name Change Date
CELEX ONCOLOGY INNOVATIONS LIMITED 28 Nov 2017